同金属多核复合体在抗癌药物开发中的应用
1Department of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 2 Dunav St., Sofia 1000, Bulgaria.
Mini reviews in medicinal chemistry
|September 15, 2025
概括
多核化合物显示出作为抗癌剂的前景. 这些金属复合物提供了增强的疗效和选择性,扩大治疗潜力超出单金属药物.
科学领域:
- 药用化学 医学化学
- 无机化学 无机化学
- 药物开发 药物开发
背景情况:
- 西斯的成功刺激了对金属基抗癌剂的研究.
- 研究IXB组金属 (Rh,Ir,Pd) 和它们的复合物,以检测它们的抗瘤特性.
- 多金属复合物提供协同效应和改善生物分布.
研究的目的:
- 审查用于癌症治疗的多核同金属化合物的最新进展.
- 突出以为基础的复合物作为抗瘤剂的潜力.
- 为了解决多核Rh基化合物的研究不足的性质.
主要方法:
- 在癌症研究中对多核复合物的文献综述.
- 分析着重于结构和功能多样性的研究.
- 对细胞毒性作用,细胞内分布和选择性的评估.
主要成果:
- 多核化合物表现出增强的细胞毒性作用.
- 这些复合体表现出更好的细胞内分布和选择性.
- 基于的化合物显示出多功能药物开发的前景.
结论:
- 多核复合体是新型抗癌疗法的有希望的候选者.
- 对这些化合物的进一步研究可能会导致先进的候选药物.
- 它们的独特特性比单核金属复合物具有优势.
相关概念视频
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Metal-Ligand Bonds
24.0K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.0K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.8K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.8K
Coordination Number and Geometry
18.9K
For transition metal complexes, the coordination number determines the geometry around the central metal ion. Table 1 compares coordination numbers to molecular geometry. The most common structures of the complexes in coordination compounds are octahedral, tetrahedral, and square planar.
18.9K


